phone icon+91-11 4195 4195
divider

Resources

separator

Intellectual Property Bulletin (April 2019)


Recently Gujarat based pharmaceutical companies Cadila Healthcare Ltd., Maan Pharmaceutical Ltd. and West Coast, have been temporarily injuncted by the Gujarat High Court from manufacturing, launching and selling Linagliptin, which is used for treating TYPE-2 Diabetes. The German Company Boehringer Ingelheim Pharma GmbH & Co. KG, has filed a suit and claimed to have a patent for Linagliptin Metformin Hydrochloride.

Download the PDF file .

separator